DEFB106B: A Protein with Potential as A Drug Target (G503841)

Target Name: DEFB106B

NCBI ID: G503841

DEFB106B

Other Name(s): Defensin beta 106B | DEFB-6 | DEFB106 | BD-6 | DEFB6

DEFB106B: A Protein with Potential as A Drug Target

Defensin beta 106B (DEFB106B) is a protein that is expressed in various tissues throughout the body, including the skin, hair, nails, and gastrointestinal tract. It is a member of the Defensin family, which is known for their role in immune surveillance and inflammation.

One of the key functions of DEFB106B is its ability to interact with the immune system. It has been shown to play a role in regulating the production of antibodies, which are proteins that are critical for fighting off infections. In addition, DEFB106B has also been shown to help regulate the immune response by preventing the activation and proliferation of immune cells that can cause damage to the body.

Another function of DEFB106B is its role in skin and hair growth and maintenance. DEFB106B has been shown to promote the growth and development of skin and hair, and it has also been shown to help maintain the integrity of the skin and hair by preventing damage from environmental factors.

In addition to its functions in immune surveillance and skin and hair growth, DEFB106B has also been shown to have potential as a drug target. Its ability to interact with immune cells and its role in promoting skin and hair growth make it an attractive target for researchers and pharmaceutical companies looking for new treatments for a variety of diseases.

One potential way to target DEFB106B is through the use of small molecules, such as drugs that can modulate its activity. These molecules have the potential to be used to treat a variety of diseases, including skin and hair growth disorders, as well as immune system disorders.

Another approach to targeting DEFB106B is through the use of antibodies. Researchers have developed antibodies that are designed to bind to DEFB106B and prevent it from interacting with immune cells. These antibodies have the potential to be used to treat a variety of diseases, including cancer and autoimmune disorders.

Overall, DEFB106B is a protein that has the potential to be a drug target or biomarker. Its ability to interact with the immune system and promote skin and hair growth make it an attractive target for researchers and pharmaceutical companies looking for new treatments for a variety of diseases.

Protein Name: Defensin Beta 106B

Functions: Has antibacterial activity (PubMed:12600824). Acts as a ligand for C-C chemokine receptor CCR2 (PubMed:23938203)

The "DEFB106B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DEFB106B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets